Chemokine CCL18 predicts intraventricular hemorrhage in very preterm infants

Annals of Medicine

Volumn 42, Issue 6, 2010, Pages 416-425

  Kallankari, Hanna ^a   Kaukola, Tuula ^a   Ojaniemi, Marja ^a   Herva, Riitta ^a   Perhomaa, Marja ^a   Vuolteenaho, Reetta ^a   Kingsmore, Stephen F ^b   Hallman, Mikko ^a  

^a UNIVERSITY OF OULU   (Finland)

^b NATIONAL CENTER FOR GENOME RESOURCES   (United States)

Author keywords

CCL18; CCR3; Chorioamnionitis; Cord blood cytokines; GM CSF; IL 4; IL 6; IL 8; Intraventricular hemorrhage; Periventricular cells

Indexed keywords

CHEMOKINE; CHEMOKINE CCL18; CHEMOKINE RECEPTOR CCR3; UNCLASSIFIED DRUG;

ARTICLE; AUTOPSY; BRAIN HEMORRHAGE; CAPILLARY ENDOTHELIUM; CHOROID PLEXUS; COHORT ANALYSIS; ECHOENCEPHALOGRAPHY; EPENDYMA CELL; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SIGNAL TRANSDUCTION; UMBILICAL CORD BLOOD;

BRAIN; CHEMOKINES, CC; FEMALE; FETAL BLOOD; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INTRACRANIAL HEMORRHAGES; MALE; PROSPECTIVE STUDIES; RECEPTORS, CCR3;

EID: 77955168941     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2010.481085     Document Type: Article

References (52)

1. McCrea HJ, Ment LR. The diagnosis, management, and postnatal prevention of intraventricular hemorrhage in the preterm neonate. Clin Perinatol. 2008;35:777-792
2. Volpe JJ. Neurology of the newborn. 5th ed. Philadelphia: Elsevier; 2008.
3. Papile LA, Burstein J, Burstein R, Koffl er H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr. 1978;92:529-534
4. Du Plessis AJ. Cerebrovascular injury in premature infants: current understanding and challenges for future prevention. Clin Perinatol. 2008;35:609-641
5. Whitelaw A. Intraventricular haemorrhage and posthaemor-rhagic hydrocephalus: pathogenesis, prevention and future interventions. Semin Neonatol. 2001;6:135-146
6. Sherlock RL, Anderson PJ, Doyle LW. Victorian Infant Collaborative Study Group. Neurodevelopmental sequelae of intraventricular haemorrhage at 8 years of age in a regional cohort of ELWB/very preterm infants. Early Hum Dev. 2005;81:909-916
7. Inder TE. Neurodevelopmental impact of low-grade intra-ventricular hemorrhage in very preterm infants. J Pediatr. 2006;149:152-154
8. Luu TM, Ment LR, Schneider KC, Katz KH, Allan WC, Vohr BR. Lasting effects of preterm birth and neonatal brain hemorrhage at 12 years of age. Pediatrics. 2009;123: 1037-1044
9. Leviton A, Paneth N, Reuss ML, Susser M, Allred EN, Dammann O, et al. Maternal infection, fetal infl ammatory response, and brain damage in very low birth weight infants. Developmental Epidemiology Network Investigators. Pediatr Res. 1999;46:566-575
10. Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM. The fetal systemic infl ammatory response. Am J Obstet Gynecol. 1998;179:194-202.
11. Heep A, Behrendt D, Nitsch P, Fimmers R, Bartmann P, Dembinski J. Increased serum levels of interleukin 6 are associated with severe intraventricular haemorrhage in extremely premature infants. Arch Dis Child Fetal Neonatal Ed. 2003;88:F501-4.
12. Tauscher MK, Berg D, Brockmann M, Seidenspinner S, Speer CP, Groneck P. Association of histologic chorioam-nionitis, increased levels of cord blood cytokines, and intrac-erebral hemorrhage in preterm neonates. Biol Neonate. 2003;83:166-170
13. Andrews WW, Goldenberg RL, Faye-Petersen O. The Alabama Preterm Birth study: polymorphonuclear and mononuclear cell placental in fi ltrations, other markers of inflammation, and outcomes in 23-to 32-week preterm newborn infants. Am J Obstet Gynecol. 2006;195:803-808
14. Babnik J, Štucin-Gantar I, Kornhauser-Cerar L, Šinkovec J, Wraber B, Derganc M. Intrauterine infl ammation and the onset of peri-intraventricular hemorrhage in premature infants. Biol Neonate. 2006;90:113-121
15. Kari MA, Hallman M, Eronen M, Teramo K, Virtanen M, Koivisto M, et al. Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: a randomized placebo-controlled multicenter study. Pediatrics. 1994;93:730-736
16. Heuchan AM, Evans N, Henderson Smart DJ, Simpson JM. Perinatal risk factors for major intraventricular haemorrhage in the Australian and New Zealand Neonatal Network, 1995-1997. Arch Dis Child Fetal Neonatal Ed. 2002;86: F86-90.
17. Dammann O, O'Shea TM. Cytokines and perinatal brain damage. Clin Perinatol. 2008;35:643-663
18. Cardona AE, Li M, Liu L, Savarin C, Ransohoff RM. Chemokines in and out of the central nervous system: much more than chemotaxis and infl ammation. Leukocyte Biol. 2008;84:587-594
19. Kaukola T, Tuimala J, Herva R, Kingsmore S, Hallman M. Cord immunoproteins as predictors of respiratory outcome in preterm infants. Am J Obstet Gynecol. 2009;200:100. e1-8.
20. Schweitzer B, Roberts S, Grimwade B, Shao W, Wang M, Fu Q, et al. Multiplexed protein profi ling on microarrays by rolling-circle signal amplifi cation. Nat Biotechnol. 2002; 20:359-365
21. Salafi a CM, Weigl C, Silberman L. The prevalence and distribution of acute placental infl ammation in uncomplicated term pregnancies. Obstet Gynecol. 1989;73:383-389
22. Kodelja V, Müller C, Politz O, Hakij N, Orfanos CE, Goerdt S. Alternative macrophage activation-associated CC-chem-okine-1, a novel structural homologue of macrophage infl ammatory protein-1 with Th2-associated expression pattern. J Immunol. 1998;160:1411-1418
23. Nibbs RJB, Salcedo TW, Campbell JDM, Yao XT, Li Y, Nardelli B, et al. CC chemokine receptor 3 antagonism by the (5-chemokine macrophage infl ammatory protein 4, a property strongly enhanced by an amino-terminal alanine-methionine swap. J Immunol. 2000;164:1488-97.
24. Salafi a CM, Minior VK, Rosenkrantz TS, Pezzullo JC, Popek EJ, Cusick W, et al. Maternal, placental, and neonatal associations with early germinal matrix/intraventricular hemorrhage in infants born before 32 weeks ' gestation. Am J Perinatol. 1995;12:429-436
25. Dammann O, Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res. 1997;42:1-8.
26. DiSalvo D. The correlation between placental pathology and intraventricular hemorrhage in preterm infant. The Developmental Epidemiology Network Investigators. Pediatr Res. 1998;43:15-19.
27. Dexter SC, Pinar H, Malee M, Hogan J, Carpenter MW, Vohr BR. Outcome of very low birth weight infants with histopathologic chorioamnionitis. Obstet Gynecol. 2000;96: 172-177
28. Vergani P, Patanè L, Doria P, Borroni C, Cappellini A, Pezzullo JC, et al. Risk factors for neonatal intraventricular haemorrhage in spontaneous prematurity at 32 weeks gestation or less. Placenta. 2000;21:402-407
29. De Felice C, Toti P, Laurini RN, Stumpo M, Picciolini E, Todros T, et al. Early neonatal brain injury in histologic chorioamnionitis. J Pediatr. 2001;138:101-104 (Pubitemid 32097149)
30. Yoon BH, Romero R, Kim CJ, Jun JK, Gomez R, Choi JH, et al. Amniotic fl uid interleukin-6: A sensitive test for antenatal diagnosis of acute infl ammatory lesions of preterm placenta and prediction of perinatal morbidity. Am J Obstet Gynecol. 1995;172:960-970
31. Sarkar S, Kaplan C, Wiswell TE, Spitzer AR. Histological chorioamnionitis and the risk of early hemorrhage in infants born or =28 weeks gestation. J Perinatol. 2005;25:749-52.
32. Richardson BS, Wakim E, daSilva O, Walton J. Preterm histologic chorioamnionitis: impact on cord gas and pH values and neonatal outcome. Am J Obstet Gynecol. 2006;195: 1357-1365
33. Wu YW. Systematic review of chorioamnionitis and cerebral palsy. Ment Retard Dev Disabil Res Rev. 2002;8:25-29
34. Schutyser E, Richmond A, Van Damme J. Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes. J Leukoc Biol. 2005;78:14-26.
35. Rostène W, Kitabgi P, Parsadaniantz SM. Chemokines: a new class of neuromodulator? Nat Rev Neurosci. 2007;8: 895-903.
36. Hieshima K, Imai T, Baba M, Shoudai K, Ishizuka K, Nakagawa T, et al. A novel human CC chemokine PARC that is most homologous to macrophage-infl ammatory protein-1/LD78 and chemotactic for T lymphocytes, but not for monocytes. J Immunol. 1997;159:1140-1149
37. Adema GJ, Hartgers F, Verstraten R, de Vries E, Marland G, Menon S, et al. A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature. 1997;387: 713-717
38. Wells TN, Peitsch MC. The chemokine information source: identifi cation and characterization of novel chemokines using WorldWideWeb and expressed sequence tag databases. J Leukoc Biol. 1997;61:545-550
39. Kaukola T, Satyaraj E, Patel DD, Tchernev VT, Grimwade BG, Kingsmore SF, et al. Cerebral palsy is characterized by protein mediators in cord serum. Ann Neurol. 2004;55:186-194
40. Koga Y, Matsuzaki A, Suminoe A, Hattori H, Hara T Expression of cytokine-associated genes in dendritic cells (DCs): comparison between adult peripheral blood-and umbilical cord blood-derived DCs by cDNA microarray. Immunol Lett. 2008;116:55-63.
41. Paneth N, Pinto-Martin J, Gardiner J, Wallenstein S, Katsikiotis V, Hegyi T, et al. Incidence and timing of germinal matrix/intraventricular hemorrhage in low birth weight infants. Am J Epidemiol. 1993;137:1167-1176
42. Berger O, Gan X, Gujuluva C, Burns AR, Sulur G, Stins M, et al. CXC and CC chemokine receptors on coronary and brain endothelia. Mol Med. 1999;5:795-805.
43. Van Der Meer P, Goldberg SH, Fung KM, Sharer LR, González, Lavi E. Expression pattern of CXCR3, CXCR4, and CCR3 chemokine receptors in the developing human brain. J Neuropathol Exp Neurol. 2001;60:25-32.
44. Elsner J, Escher SE, Forssmann U. Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases. Allergy. 2004;59:1243-1258
45. Fujisawa T, Kato Y, Nagase H, Atsuta J, Terada A, Iguchi K, et al. Chemokines induce eosinophil degranulation through CCR-3. J Allergy Clin Immunol. 2000;106:507-513
46. Chang CY, Lee YH, Leu SJ, Wang CY, Wei CP, Hung KS, et al. CC-chemokine ligand 18/pulmonary activation-regulated chemokine expression in the CNS with special reference to traumatic brain injuries and neoplastic disorders. Neuroscience. 2010;165:1233-1243
47. Vulcano M, Struyf S, Scapini P, Cassatella M, Bernasconi S, Bonecchi R, et al. Unique regulation of CCL18 production by maturing dendritic cells. J Immunol. 2003;170:3843-3849
48. Salcedo R, Young HA, Ponce ML, Ward JM, Kleinman HK, Murphy WJ, et al. Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells. J Immunol. 2001;166:7571-7578
49. Hillyer P, Mordelet E, Flynn G, Male D. Chemokines, chem-okine receptors and adhesion molecules on different human endothelia: discriminating the tissue-specifi c functions that affect leukocyte migration. Clin Exp Immunol. 2003;134: 431-441
50. Ricciardi A, Elia AR, Cappello P, Puppo M, Vanni C, Fardin P, et al. Transcriptome of hypoxic immature dendritic cells: modulation of chemokine/receptor expression. Mol Cancer Res. 2008;6:175-185
51. Ballabh P. Intraventricular hemorrhage in premature infants: Mechanism of disease. Pediatr Res. 2010;67:1-8.
52. Atamas SP, Luzina IG, Choi J, Tsymbalyuk N, Carbonetti NH, Singh IS, et al. Pulmonary and activation-regulated chemokine stimulates collagen production in lung fi broblasts. Am J Respir Cell Mol Biol. 2003;29:743-749